PPARGC1A and liver dysplastic nodule: Their results showed that OS was the pharmacological target of RESV and that its powerful antioxidant properties probably significantly contributed to its protective effect against podocyte damage in mice with DN, which was mediated through the SIRT1-PGC-1α pathway [41,96].